Ongoing oral anticoagulation appears to do more harm than good in patients with atrial high-rate episodes (AHREs) unaccompanied by EKG-documented atrial fibrillation (AF). A recent analysis from the Competence Network on Atrial Fibrillation (AFNET) provides this insight. The clinical study NOAH – AFNET 6 (non-vitamin K antagonist oral anticoagulants in ...
ESC 2023 – Anticoagulation for Precursor Atrial Fibrillation?
Dr. med. Thomas Kron
|
Conference Report
|
30 August 2023
Register or log in to read more
Registration is free and easy, giving you complete access to all Univadis content.
Create a Free Account I have an account